EDGAR Filing Documents for 0001104659-23-093038

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001104659-23-093038

Filing Date

2023-08-17

Accepted

2023-08-17 16:05:28

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	tm2323629d1_424b5.htm	424B5	604795
2	GRAPHIC	tm2323629d1_424b5img001.jpg	GRAPHIC	5077
3	GRAPHIC	tm2323629d1_prossupsp2img001.jpg	GRAPHIC	5287
4	GRAPHIC	tm232362d1_img001.jpg	GRAPHIC	9930
	Complete submission text file	0001104659-23-093038.txt		634377

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807

Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300

RVL Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269440 | Film No.: 231181878
SIC: 2834 Pharmaceutical Preparations